Symptomatic primary cytomegalovirus infection in a HIV-positive pregnant woman.

Bergin, Sarah; Ferguson, Wendy; Corcoran, Suzanne; Varughese, Allan; Byrne, David; Lawless, Mairead; Eogan, Maeve; Lambert, John S

dc.contributor.author	Bergin, Sarah
dc.contributor.author	Ferguson, Wendy
dc.contributor.author	Corcoran, Suzanne
dc.contributor.author	Varughese, Allan
dc.contributor.author	Byrne, David
dc.contributor.author	Lawless, Mairead
dc.contributor.author	Eogan, Maeve
dc.contributor.author	Lambert, John S
dc.date.accessioned	2014-11-26T10:24:32Z	en
dc.date.available	2014-11-26T10:24:32Z	en
dc.date.issued	2014-12	en
dc.identifier.citation	Bergin, S. et al., 2014. Symptomatic primary cytomegalovirus infection in a HIV-positive pregnant woman. International Journal of STD & AIDS. 2014, 25 (14) pp 1041-3	en_GB
dc.identifier.issn	1758-1052	en
dc.identifier.pmid	24648317	en
dc.identifier.doi	10.1177/0956462414528314	en
dc.identifier.uri	http://hdl.handle.net/10147/336153	en
dc.description.abstract	We describe a case of symptomatic primary Cytomegalovirus infection in a HIV-positive pregnant woman on antiretroviral treatment with a CD4 count >200 × 10(6)/l requiring intravenous ganciclovir. No adverse consequences from ganciclovir or evidence of congenital Cytomegalovirus infection were found.
dc.language.iso	en	en
dc.rights	Archived with thanks to International journal of STD & AIDS	en_GB
dc.subject	PREGNANCY	en_GB
dc.subject	HIV INFECTION	en_GB
dc.subject.other	CYTOMEGALOVIRUS	en_GB
dc.title	Symptomatic primary cytomegalovirus infection in a HIV-positive pregnant woman.	en_GB
dc.type	Article	en
dc.contributor.department	Clinical Microbiology, Beaumont Hospital, Dublin, Ireland Clinical Microbiology, Rotunda Hospital, Dublin, Ireland sarahbergin1@hotmail.com.	en_GB
dc.identifier.journal	International Journal of STD & AIDS	en_GB
dc.description.funding	Other	en
dc.description.province	Leinster	en
dc.description.peer-review	peer-review	en
refterms.dateFOA	2016-01-31T00:00:00Z
html.description.abstract	We describe a case of symptomatic primary Cytomegalovirus infection in a HIV-positive pregnant woman on antiretroviral treatment with a CD4 count >200 × 10(6)/l requiring intravenous ganciclovir. No adverse consequences from ganciclovir or evidence of congenital Cytomegalovirus infection were found.